RFL

Rafael Holdings, Inc.

RFL, USA

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

https://www.rafaelholdings.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
RFL
stock
RFL

Market Outlook: Is RFL stock undervalued historically - July 2025 Trends & Accurate Entry and Exit Point Alerts moha.gov.vn

Read more →
RFL
stock
RFL

National fittings Ltd Growth - Long-Term Growth Stocks & Receive Monthly Expert Trading Blueprints Bollywood Helpline

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-07-31)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.58

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-12.81 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-10.60 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-2,965.71 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.17

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 16.06% of the total shares of Rafael Holdings, Inc.

1.

Vanguard Group Inc

(3.5944%)

since

2025/06/30

2.

Vanguard Total Stock Mkt Idx Inv

(2.0927%)

since

2025/07/31

3.

Geode Capital Management, LLC

(1.2852%)

since

2025/06/30

4.

BlackRock Inc

(1.1225%)

since

2025/06/30

5.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0236%)

since

2025/07/31

6.

Dimensional Fund Advisors, Inc.

(0.9604%)

since

2025/06/30

7.

Fidelity Extended Market Index

(0.661%)

since

2025/07/31

8.

IEQ CAPITAL, LLC

(0.6382%)

since

2025/06/30

9.

Founders Fund V Management, LLC

(0.4827%)

since

2025/06/30

10.

Kahn Brothers & CO Inc /DE/

(0.4588%)

since

2025/06/30

11.

DFA US Micro Cap I

(0.3253%)

since

2025/07/31

12.

iShares Micro-Cap ETF

(0.3179%)

since

2025/08/31

13.

Cable Car Capital LLC

(0.2849%)

since

2025/06/30

14.

Fidelity Total Market Index

(0.2153%)

since

2025/07/31

15.

Spartan Extended Market Index Pool F

(0.1781%)

since

2025/07/31

16.

State Street Corp

(0.1771%)

since

2025/06/30

17.

Northern Trust Corp

(0.1729%)

since

2025/06/30

18.

Fidelity Series Total Market Index

(0.16%)

since

2025/07/31

19.

T. Rowe Price Extended Equity Market Idx

(0.1291%)

since

2025/07/31

20.

HPM Partners LLC

(0.1256%)

since

2025/06/30

21.

Americana Partners, LLC

(0.1248%)

since

2025/06/30

22.

Founders Fund VI Management, LLC

(0.1105%)

since

2025/06/30

23.

Vanguard U.S. Eq Idx £ Acc

(0.1032%)

since

2025/07/31

24.

Extended Equity Market Fund K

(0.1028%)

since

2025/06/30

25.

Spartan Total Market Index Pool G

(0.1026%)

since

2025/07/31

26.

LPL Financial Corp

(0.0974%)

since

2025/06/30

27.

Renaissance Technologies Corp

(0.085%)

since

2025/06/30

28.

T. Rowe Price Associates, Inc.

(0.0835%)

since

2025/06/30

29.

NT Ext Equity Mkt Idx Fd - L

(0.0824%)

since

2025/06/30

30.

Northern Trust Extended Eq Market Idx

(0.0824%)

since

2025/06/30

31.

Marshall Wace Asset Management Ltd

(0.0818%)

since

2025/06/30

32.

Susquehanna International Group, LLP

(0.0806%)

since

2025/06/30

33.

Vanguard Balanced Index Inv

(0.0795%)

since

2025/07/31

34.

Dimensional US Small Cap ETF

(0.079%)

since

2025/08/29

35.

Advisor Group Holdings, Inc.

(0.0687%)

since

2025/06/30

36.

Wells Fargo & Co

(0.0669%)

since

2025/06/30

37.

DFA US Vector Equity I

(0.0585%)

since

2025/07/31

38.

DFA US Core Equity 2 I

(0.0576%)

since

2025/07/31

39.

DFA US Core Equity 1 I

(0.0561%)

since

2025/07/31

40.

Dimensional US Targeted Value ETF

(0.0515%)

since

2025/08/29

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-10-31

EPS Actual

—

EPS Estimate

—

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-07-31)

Deep Value
Potential Value Candidate(6)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2)
Net Net
Possible Net-Net(3.5)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-07-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-07-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-07-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.